Overview

A Study of Tirzepatide in Overweight and Very Overweight Participants

Status:
Recruiting
Trial end date:
2022-06-25
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to measure the effect of tirzepatide on food intake in participants who are overweight or very overweight. The study will also use imaging to learn more about how tirzepatide affects specific parts of the brain. The effect of tirzepatide on appetite will also be studied. The study will last up to about four months and will include up to 14 visits to the study center.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Liraglutide
Tirzepatide